Charles A Rowland Jr Nabriva Therapeutics PLC (NBRV) insider trading activity

Charles A Rowland Jr is Director of Nabriva Therapeutics plc. Currently has a direct ownership of 15,277 shares of NBRV, which is worth approximately $6,110. The most recent transaction as insider was on Aug 01, 2022, when has been sold 8,496 shares (Ordinary Shares) at a price of $0.18 per share, resulting in proceeds of $1,529. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.3K

0% 3M change

0% 12M change

Total Value Held $6,110

Charles A Rowland Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 01 2022	SELL Open market or private sale	$1,529 $0.18 p/Share	8,496 Reduced 35.74%	15,277 Ordinary Shares
Aug 02 2021	SELL Open market or private sale	$932 $1.2 p/Share	777 Reduced 3.16%	23,773 Ordinary Shares
Jul 28 2021	BUY Grant, award, or other acquisition	-	17,500 Added 41.62%	24,550 Ordinary Shares

Also insider at

BPMC

Blueprint Medicines Corp Healthcare

Director

GBIO

Generation Bio Co. Healthcare

VKTX

Viking Therapeutics, Inc. Healthcare

Director

ORTX

Orchard Therapeutics plc Healthcare

CAR